Compare ADMA & MAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADMA | MAT |
|---|---|---|
| Founded | 2004 | 1945 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 5.1B |
| IPO Year | 2012 | 1994 |
| Metric | ADMA | MAT |
|---|---|---|
| Price | $15.52 | $17.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $28.50 | $21.00 |
| AVG Volume (30 Days) | 2.0M | ★ 6.7M |
| Earning Date | 04-02-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 723.08 | N/A |
| EPS | 0.40 | ★ 1.24 |
| Revenue | $42,219,783.00 | ★ $5,347,623,000.00 |
| Revenue This Year | $22.13 | $5.73 |
| Revenue Next Year | $24.12 | $5.66 |
| P/E Ratio | $40.51 | ★ $19.08 |
| Revenue Growth | ★ 43.85 | N/A |
| 52 Week Low | $13.50 | $13.95 |
| 52 Week High | $25.67 | $22.48 |
| Indicator | ADMA | MAT |
|---|---|---|
| Relative Strength Index (RSI) | 43.54 | 37.14 |
| Support Level | $15.56 | $16.93 |
| Resistance Level | $16.67 | $19.46 |
| Average True Range (ATR) | 0.62 | 0.77 |
| MACD | 0.05 | -0.19 |
| Stochastic Oscillator | 30.97 | 35.10 |
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
Mattel manufactures and markets toy products that are sold to its wholesale and direct to retail customers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2024, with the remainder stemming from international markets.